Siringo, M.; Gentile, G.; Caponnetto, S.; Sperduti, I.; Santini, D.; Cortesi, E.; Gelibter, A.J.
Evaluation of Efficacy of ALK Inhibitors According to Body Mass Index in ALK Rearranged NSCLC Patients—A Retrospective Observational Study. Cancers 2023, 15, 3422.
https://doi.org/10.3390/cancers15133422
AMA Style
Siringo M, Gentile G, Caponnetto S, Sperduti I, Santini D, Cortesi E, Gelibter AJ.
Evaluation of Efficacy of ALK Inhibitors According to Body Mass Index in ALK Rearranged NSCLC Patients—A Retrospective Observational Study. Cancers. 2023; 15(13):3422.
https://doi.org/10.3390/cancers15133422
Chicago/Turabian Style
Siringo, Marco, Gabriella Gentile, Salvatore Caponnetto, Isabella Sperduti, Daniele Santini, Enrico Cortesi, and Alain Jonathan Gelibter.
2023. "Evaluation of Efficacy of ALK Inhibitors According to Body Mass Index in ALK Rearranged NSCLC Patients—A Retrospective Observational Study" Cancers 15, no. 13: 3422.
https://doi.org/10.3390/cancers15133422
APA Style
Siringo, M., Gentile, G., Caponnetto, S., Sperduti, I., Santini, D., Cortesi, E., & Gelibter, A. J.
(2023). Evaluation of Efficacy of ALK Inhibitors According to Body Mass Index in ALK Rearranged NSCLC Patients—A Retrospective Observational Study. Cancers, 15(13), 3422.
https://doi.org/10.3390/cancers15133422